n.ibarra
TL2 · Córdoba
Contributes reviews on supplier material. Based in Córdoba.
Joined 24 March 2025 · last posted 2d
75 posts, newest first. Showing up to 150.
-
Alcohol: what is documented and what is folklore Replied, post #134 · Practice › Interactions · 26 Jul 2026 · 0 likes Adding a reference point for alcohol. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
-
Revisiting: The best-written scientific paper you have read Replied, post #110 · Lounge › Off topic · 23 Jul 2026 · 20 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #47 · Analytics › Mass spectrometry · 21 Jul 2026 · 1 like Where the 2 ppm match reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
A pooled estimate that changed when one trial was added Replied, post #26 · Evidence › Meta-analyses · 20 Jul 2026 · 6 likes Adding the measurement that post #23 says would settle it. Fixed-effect and random-effects models answer different questions. The first assumes one true effect; the…
-
What a certificate commits its issuer to Replied, post #37 · Analytics › COA interpretation · 15 Jul 2026 · 1 like Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #60 · Compounds › Retatrutide · 13 Jul 2026 · 20 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
The anatomy of a question that gets answered within an hour Replied, post #105 · Start Here › How to Ask · 8 Jul 2026 · 24 likes Post #102 is right about the mechanism and I think understates the practical bit. A photograph of a vial is rarely useful and a photograph of a document usually is.…
-
Tracking a shortage from primary sources rather than rumour Replied, post #79 · Access › Shortages · 1 Jul 2026 · 2 likes Building on post #78 rather than restating it. A shortage of one presentation is not a shortage of all of them, and the published notices are specific about which.…
-
Common supplements people ask about, assessed one at a time Started this topic · Practice › Interactions · 30 Jun 2026 · 5 likes Common supplements people ask about, assessed one at a time — setting out what I have, and where I think it stops being reliable. A follow-up question about common…
-
What I would want from a home test that does not exist yet Replied, post #21 · Analytics › Home & field testing · 27 Jun 2026 · 3 likes Research-use-only material is not certified for anything by anybody, and no home procedure changes that. What home checks buy you is early detection of the obvious…
-
Reading a home test result without over-claiming Replied, post #89 · Analytics › Home & field testing · 22 Jun 2026 · 3 likes Research-use-only material is not certified for anything by anybody, and no home procedure changes that. What home checks buy you is early detection of the obvious…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #13 · Outcomes › Body composition · 11 Jun 2026 · 7 likes Percentage body fat is a ratio, so it changes when either component changes. A rising percentage during weight loss is arithmetic before it is physiology. Adding this…
-
Racemisation and why it is invisible to a mass measurement Replied, post #48 · Analytics › Impurities & related substances · 11 Jun 2026 · 15 likes An update on my earlier racemisation post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #8 · Start Here › How to Ask · 30 May 2026 · 26 likes Answering the question post #6 raises rather than the one it answers. Context that matters: compound, how long in, current dose, relevant history. Context that does not…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #12 · Compounds › Oral incretins · 23 May 2026 · 23 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #81 · Practice › Side effects · 16 May 2026 · 22 likes Genuine question rather than a rhetorical one: has anyone here actually observed Dizziness on standing, as opposed to read about it? The thread is long and I cannot tell.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #63 · Evidence › Trials · 9 Apr 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Personal import allowances, compared — a second dataset Replied, post #99 · Access › International · 7 Apr 2026 · 0 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks. If…
-
Transporting a vial for a weekend away — a second dataset Replied, post #21 · Practice › Storage & stability · 5 Apr 2026 · 3 likes Everything in post #17 holds. The case it does not cover is the one I have. Container choice matters: the material of the vial, the rubber closure, the fill volume all…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #34 · Practice › Administration · 4 Apr 2026 · 32 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Reading an interaction checker output critically Replied, post #140 · Practice › Interactions · 8 Mar 2026 · 18 likes Useful. I have added it to my own notes with the date on it.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #15 · Clinical › Comorbidities · 27 Feb 2026 · 32 likes Reading back through the type 2 diabetes threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
-
Revisiting: Maintainer handover: how it works Replied, post #2 · Meta › Wiki maintenance · 16 Feb 2026 · 27 likes That is the distinction I keep failing to hold on to. Written down now.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #106 · Practice › Interactions · 7 Feb 2026 · 13 likes Building on post #104 rather than restating it. What I would want before treating Warfarin and altered intake as settled: the method, the sample, and whether anyone…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #8 · Outcomes › Progress reports · 6 Feb 2026 · 0 likes Weighing daily and reporting weekly is a better protocol than weighing weekly, because it separates the measurement frequency from the reporting frequency. A guess,…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #66 · Sourcing › Red flags · 27 Jan 2026 · 1 like Post #63 is the version of this I will quote in future. One addition. A stock listing that never changes and a lead time that never varies are both worth noticing. Real…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #90 · Practice › Interactions · 15 Jan 2026 · 7 likes Taking Warfarin and altered intake seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #17 · Sourcing › Independent verification · 4 Jan 2026 · 0 likes Two questions I would want answered before drawing anything from the Janoshik data above: how were the cases selected, and what happened to the ones that dropped out.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #30 · Meta › Site feedback · 28 Dec 2025 · 6 likes Picking up post #29: that is the part I would want checked first. Feature request framed as feedback: the category list is long enough that a first-time reader cannot…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #14 · Research Methods › N-of-1 designs · 25 Dec 2025 · 0 likes Post #13 answers the question as asked. The question underneath it is different. Blinding yourself is harder than it sounds and is not impossible. Somebody else…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #24 · Access › International · 24 Dec 2025 · 7 likes I would keep Language barriers in accessing and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #54 · Clinical › Special populations · 17 Dec 2025 · 25 likes Where I part company with post #50, and it is a narrow parting. Older adults was covered in the wiki last year and the page has a review date on it, which is a better…
-
Tracking a preprint to publication: a worked example Replied, post #73 · Evidence › Preprints · 7 Dec 2025 · 15 likes Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which is what it is designed to do.
-
Cost per delivered dose, which is the number that matters Replied, post #27 · Access › Pricing · 4 Dec 2025 · 2 likes Landed cost including shipping, fees and currency conversion is what you actually pay, and quotes that look identical frequently are not. Filing this under things that…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #20 · Pharmacology › Pharmacokinetics · 16 Nov 2025 · 5 likes No notes. Posting so the count is not one.
-
Pen dose counters: what a click does and does not guarantee Replied, post #40 · Devices › Pens & autoinjectors · 15 Nov 2025 · 6 likes The arithmetic in post #37 is right; the assumption feeding it is the part to check. Nothing here is medical advice, and pen technique is the single easiest thing to…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #11 · Sourcing › Independent verification · 12 Nov 2025 · 2 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. Requesting the batch record rather than the certificate is a reasonable escalation…
-
A preprint whose numbers changed substantially at publication — what changed since Replied, post #6 · Evidence › Preprints · 3 Nov 2025 · 9 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #84 · Safety › Adverse events · 2 Nov 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Alcohol: what is documented and what is folklore — the long version Replied, post #2 · marked as the solution · Practice › Interactions · 25 Oct 2025 · 7 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #48 · Evidence › Journal club · 24 Oct 2025 · 6 likes I had written a reply contradicting post #46 and deleted it. Here is what survived. Sessions on negative or null results are consistently the most instructive and the…
-
An orphaned page with no inbound links — the long version Replied, post #18 · Meta › Wiki maintenance · 11 Oct 2025 · 0 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. Fair — and in this case it can, because it contains a number. So:…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #98 · Analytics › HPLC & UHPLC · 7 Oct 2025 · 4 likes Carryover from a previous injection shows up as a small peak at the same retention time in a blank. A method report that includes a blank injection is telling you the…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #70 · Practice › Storage & stability · 25 Sep 2025 · 10 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #48 · Analytics › COA interpretation · 24 Sep 2025 · 25 likes Post #47 put the caveat in the right place and I want to underline it. Peptide content and chromatographic purity are separate determinations and a certificate that…
-
Documentation that appears only after payment Replied, post #29 · Sourcing › Red flags · 20 Sep 2025 · 20 likes The strongest argument against my own position on documentation, stated as well as I can state it, since nobody else has yet.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #73 · Analytics › HPLC & UHPLC · 17 Sep 2025 · 11 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
Specification in the result column: why that is a meaningful error Replied, post #43 · Analytics › COA interpretation · 12 Sep 2025 · 0 likes Agreed on all of that, and I have nothing to add to it.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #114 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Reading this Aggregated purity results across four thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #9 · Clinical › Special populations · 13 Aug 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
A ten-fold dose error caught before injection Replied, post #66 · Devices › Syringes & needles · 17 Jul 2025 · 23 likes Ten-fold dose error caught looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #143 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2025 · 12 likes Adding the measurement that post #141 says would settle it. The phase 3 combination programme is where the clinically interesting numbers will come from. Phase 2…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #18 · Practice › Reconstitution · 4 Jun 2025 · 13 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #80 · Data & Tools › Calculators · 20 May 2025 · 1 like Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #48 · Compounds › Retatrutide · 9 May 2025 · 12 likes Answering the question post #46 raises rather than the one it answers. The practical version of Triple agonism is three sentences long. The rigorous version is three…
-
An orphaned page with no inbound links Replied, post #38 · Meta › Wiki maintenance · 9 May 2025 · 5 likes Everything in post #36 holds. The case it does not cover is the one I have. Requesting a review date change rather than a content change. This page is being read far…
-
Follow-up: Documentation that appears only after payment Replied, post #36 · Sourcing › Red flags · 1 May 2025 · 0 likes Reporting rather than recommending, on Documentation. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #60 · Practice › Reconstitution · 30 Apr 2025 · 15 likes Picking up post #57: that is the part I would want checked first. Having read the whole 5 mg vial thread before replying: the question in the first post has not…
-
Retatrutide dose escalation in the published trials Replied, post #141 · Compounds › Retatrutide · 16 Apr 2025 · 1 like Whatever the answer on retatrutide dose escalation turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
-
Certificates issued by the seller versus by a laboratory Replied, post #17 · Analytics › COA interpretation · 25 Mar 2025 · 4 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Charge states for a 4 kDa peptide, worked through Replied, post #58 · Analytics › Mass spectrometry · 9 Mar 2025 · 7 likes What I can speak to on charge states is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #35 · Compounds › Tirzepatide · 8 Mar 2025 · 26 likes Adding thanks rather than a view. I do not have a view worth the space.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #72 · Compounds › Semaglutide · 21 Feb 2025 · 22 likes Reporting rather than recommending, on published dose-response for semaglutide. What happened is above. Whether it should have is a different question and not one I am…
-
Reading a supplementary appendix and finding the interesting part Replied, post #91 · Evidence › Trials · 12 Feb 2025 · 14 likes I would rather this thread reach "we do not know" about reading a supplementary appendix than reach a confident answer that nobody can support when asked.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #97 · Devices › Syringes & needles · 10 Jan 2025 · 1 like This follows post #96 rather than contradicting it. Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #13 · Practice › Dosing & titration · 9 Jan 2025 · 6 likes Post #10 is the version of this I will quote in future. One addition. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #8 · Analytics › Mass spectrometry · 21 Dec 2024 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #40 · Evidence › Trials · 17 Dec 2024 · 12 likes Building on post #39 rather than restating it. Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #72 · Devices › Syringes & needles · 27 Nov 2024 · 2 likes Drawing through a wider needle and injecting through a thinner one is a reasonable approach for a viscous preparation and pointless for an aqueous one.
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #31 · Nutrition & Training › Resistance training · 19 Nov 2024 · 4 likes I keep a log for Recovery specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
-
Time to steady state after a dose increase Replied, post #88 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 5 likes Answering the question post #84 raises rather than the one it answers. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide…
-
A side-effect grading scheme this community uses, and its limits — the long version Started this topic · Practice › Side effects · 25 Oct 2024 · 1 like A side-effect grading scheme this community uses, and its limits — the long version — setting out what I have, and where I think it stops being reliable. A narrow…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #12 · Evidence › Journal club · 7 Aug 2024 · 13 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes.…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #31 · Safety › Contraindications · 25 Jul 2024 · 0 likes A rodent toxicology finding underlying a contraindication is worth understanding, because it explains why the contraindication is narrow rather than broad. If that is…
-
Journal club: FLOW and the renal composite, component by component Replied, post #87 · Evidence › Journal club · 17 Jul 2024 · 22 likes The arithmetic in post #86 is right; the assumption feeding it is the part to check. The figures usually contain the finding and the text usually contains the…